Noridian opens three proposed MolDX policies for comments through October 11
Sep 6, 2026 edition · GC-2026-0033 · Published 2026-09-06 · Version 2 · Proposed
Noridian’s three proposed MolDX policies accept comments through October 11. They concern different molecular-testing questions and are not final coverage instructions.
What happened
Noridian’s August 31 Jurisdiction E notice opens review of three proposed MolDX LCDs for the August 27–October 11 comment period. DL40435 concerns transcriptional biomarkers for treatment decisions in renal carcinoma; DL40427 covers next-generation sequencing for hematologic malignancies and suspected malignancies; DL40411 concerns genome-wide detection of copy-number alterations and structural variants in hematologic neoplasms. The notice identifies Part B contractor jurisdictions including northern and southern California, Hawaii/Pacific territories and Nevada.
The notice links the individual proposals through the Medicare Coverage Database and asks commenters to identify the specific policy in each submission. Each addresses a different test and clinical question, so comments should connect the relevant test menu and supporting evidence to that proposal. Publishing a draft for comment does not make its coverage criteria final or implement a current billing change. The October 11 opportunity remains open at each September coverage cutoff; later finalization or revision is not presumed.
Scope and timing
- Authority status
- Proposed
- Applicability
- Potentially applicable
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal, California, Hawaii, Nevada
- Affected functions
- Coding, Clinical Operations, Revenue Cycle, Compliance
- Responsible owner
- Coding
- Recorded date
- 2026-10-11
- Date type
- comment
Why it matters
Policy-specific review can identify whether a proposal affects an actual testing service. Treating draft criteria as operative could lead to premature coverage or billing changes.
Recommended action
Compare relevant tests with each actual proposed LCD and decide whether to submit policy-specific evidence by October 11. Keep this review separate from implementation of already-finalized MolDX changes.
Sources
- Multiple MolDX proposed LCDs published for review and commentsOfficial · Noridian, Jurisdiction E · 2026-08-31 · Source review 2026-09-06
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →